NOVARTIS CAPITAL P Buy Hold or Sell Recommendation
| 66989HAS7 | 68.91 5.89 9.35% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding NOVARTIS CAPITAL P is 'Strong Sell'. Macroaxis provides NOVARTIS buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NOVARTIS positions.
Check out NOVARTIS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Also, note that the market value of any corporate bond could be closely tied with the direction of predictive economic indicators such as signals in nation.
NOVARTIS |
Execute NOVARTIS Buy or Sell Advice
The NOVARTIS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NOVARTIS CAPITAL P. Macroaxis does not own or have any residual interests in NOVARTIS CAPITAL P or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NOVARTIS's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds of Default | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details |
NOVARTIS Returns Distribution Density
The distribution of NOVARTIS's historical returns is an attempt to chart the uncertainty of NOVARTIS's future price movements. The chart of the probability distribution of NOVARTIS daily returns describes the distribution of returns around its average expected value. We use NOVARTIS CAPITAL P price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NOVARTIS returns is essential to provide solid investment advice for NOVARTIS.
| Mean Return | 0.05 | Value At Risk | -2.92 | Potential Upside | 2.24 | Standard Deviation | 3.56 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NOVARTIS historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NOVARTIS Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NOVARTIS or Financial Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NOVARTIS's price will be affected by overall bond market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NOVARTIS bond's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 2.04 | |
Ir | Information ratio | 0 |
NOVARTIS Volatility Alert
NOVARTIS CAPITAL P currently demonstrates below-average downside deviation. It has Information Ratio of 0.0 and Jensen Alpha of 0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NOVARTIS's bond risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NOVARTIS's bond price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NOVARTIS Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NOVARTIS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.09 | |||
| Day Median Price | 68.91 | |||
| Day Typical Price | 68.91 | |||
| Price Action Indicator | 2.94 | |||
| Period Momentum Indicator | 5.89 | |||
| Relative Strength Index | 29.3 |
About NOVARTIS Buy or Sell Advice
When is the right time to buy or sell NOVARTIS CAPITAL P? Buying financial instruments such as NOVARTIS Bond isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NOVARTIS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 89 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in NOVARTIS Bond
NOVARTIS financial ratios help investors to determine whether NOVARTIS Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVARTIS with respect to the benefits of owning NOVARTIS security.